These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9352580)

  • 1. Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients.
    Suzuki A; Otani K; Mihara K; Yasui N; Kaneko S; Inoue Y; Hayashi K
    Pharmacogenetics; 1997 Oct; 7(5):415-8. PubMed ID: 9352580
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia.
    Mihara K; Suzuki A; Kondo T; Yasui N; Furukori H; Nagashima U; Ono S; Kaneko S; Otani K; Inoue Y
    Ther Drug Monit; 2000 Jun; 22(3):245-9. PubMed ID: 10850389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients.
    Roh HK; Chung JY; Oh DY; Park CS; Svensson JO; Dahl ML; Bertilsson L
    Br J Clin Pharmacol; 2001 Sep; 52(3):265-71. PubMed ID: 11560558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between the steady-state plasma concentrations of haloperidol and risperidone.
    Yasui-Furukori N; Kondo T; Mihara K; Suzuki A; Inoue Y; De Vries R; Kaneko S
    J Clin Pharmacol; 2002 Oct; 42(10):1083-8. PubMed ID: 12362921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia.
    Mihara K; Suzuki A; Kondo T; Yasui N; Furukori H; Nagashima U; Otani K; Kaneko S; Inoue Y
    Clin Pharmacol Ther; 1999 Mar; 65(3):291-4. PubMed ID: 10096261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients.
    Pan L; Vander Stichele R; Rosseel MT; Berlo JA; De Schepper N; Belpaire FM
    Ther Drug Monit; 1999 Oct; 21(5):489-97. PubMed ID: 10519444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.
    van der Weide K; van der Weide J
    J Clin Psychopharmacol; 2015 Jun; 35(3):228-36. PubMed ID: 25868121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6.
    Ohnuma T; Shibata N; Matsubara Y; Arai H
    Br J Clin Pharmacol; 2003 Sep; 56(3):315-20. PubMed ID: 12919180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2D6*10 alleles are not the determinant of the plasma haloperidol concentrations in Asian patients.
    Shimoda K; Morita S; Yokono A; Someya T; Hirokane G; Sunahara N; Takahashi S
    Ther Drug Monit; 2000 Aug; 22(4):392-6. PubMed ID: 10942177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite.
    Suzuki A; Otani K; Mihara K; Yasui N; Kondo T; Tokinaga N; Furukori H; Kaneko S; Inoue Y; Hayashi K
    Psychopharmacology (Berl); 1998 Feb; 135(4):333-7. PubMed ID: 9539256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome.
    Panagiotidis G; Arthur HW; Lindh JD; Dahl ML; Sjöqvist F
    Ther Drug Monit; 2007 Aug; 29(4):417-22. PubMed ID: 17667795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia.
    Yasui-Furukori N; Mihara K; Kondo T; Kubota T; Iga T; Takarada Y; De Vries R; Kaneko S; Tateishi T
    J Clin Pharmacol; 2003 Feb; 43(2):122-7. PubMed ID: 12616663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 II D6 gene polymorphisms and the neuroleptic-induced extrapyramidal symptoms in Japanese schizophrenic patients.
    Inada T; Senoo H; Iijima Y; Yamauchi T; Yagi G
    Psychiatr Genet; 2003 Sep; 13(3):163-8. PubMed ID: 12960748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol.
    Suzuki Y; Someya T; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S
    Ther Drug Monit; 2001 Aug; 23(4):363-8. PubMed ID: 11477317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between the steady-state plasma concentrations of aripiprazole and haloperidol in Japanese patients with schizophrenia.
    Nakamura A; Mihara K; Nemoto K; Nagai G; Kagawa S; Suzuki T; Kondo T
    Ther Drug Monit; 2014 Dec; 36(6):815-8. PubMed ID: 24739668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol.
    Yasui-Furukori N; Kondo T; Suzuki A; Mihara K; Tokinaga N; Inoue Y; Otani K; Kaneko S
    Schizophr Res; 2001 Oct; 52(1-2):139-42. PubMed ID: 11595402
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: a preliminary study in a psychiatric population.
    Someya T; Suzuki Y; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S
    Psychiatry Clin Neurosci; 1999 Oct; 53(5):593-7. PubMed ID: 10595685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population.
    Someya T; Shimoda K; Suzuki Y; Sato S; Kawashima Y; Hirokane G; Morita S; Yokono A; Takahashi S
    Neuropsychopharmacology; 2003 Aug; 28(8):1501-5. PubMed ID: 12784098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic association between cytochrome P-450 2D6 gene polymorphism and plasma concentration of haloperidol in Japanese schizophrenics.
    Shibata N; Ohnuma T; Baba H; Shimada H; Takahashi T; Arai H
    Psychiatr Genet; 1999 Sep; 9(3):145-8. PubMed ID: 10551545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment.
    Brockmöller J; Kirchheiner J; Schmider J; Walter S; Sachse C; Müller-Oerlinghausen B; Roots I
    Clin Pharmacol Ther; 2002 Oct; 72(4):438-52. PubMed ID: 12386646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.